Cancer clinical trials in Korea have rapidly progressed in terms of quantity and quality during the last decade. This study evaluates the current status of cancer clinical trials in Korea and their associated problems.We analyzed the clinical trials approved by the Korea Food and Drug Administration (KFDA) between 2007 and 2013. A nationwide on-line survey containing 22 questions was also performed with several cooperative study groups and individual researchers in 56 academic hospitals.The number of cancer clinical trials approved by the KFDA increased almost twofold from 2007 to 2013. The number of sponsor-initiated clinical trials (SITs) increased by 50
作者:Byoung Yong, Shim;Se Hoon, Park;Soonil, Lee;Jin-Soo, Kim;Kyoung Eun, Lee;Yoon-Koo, Kang;Myung-Ju, Ahn
来源:Cancer research and treatment : official journal of Korean Cancer Association 2016 年 48卷 1期